CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $) In Thousands, except Share data	Total		Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (AOCI)	Non- Controlling Interest
Beginning balance at Dec. 31, 2010	$ 228,429		$ 39	$ (12,031)	$ 3,541,044	$ (3,305,299)	$ 54	$ 4,622
Beginning balance (in shares) at Dec. 31, 2010			39,439,000	(2,440,000)
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options	2,252				2,252
Equity-based compensation related to deferred stock units (DSUs)	703				703
Equity-based compensation related to restricted stock (RS)	851				851
Issuance of DSUs	165				165
Issuance of DSUs, shares			73,000
Issuance of RS, net of forfeitures and surrenders	(31)		1		(32)
Issuance of RS, net of forfeitures and surrenders, shares			1,178,000
Exercise of SARs and stock options, net of surrenders	3		1		2
Exercise of SARs and stock options, net of surrenders, shares	(18,725)	[1]	39,000
Repurchase of ICGE common stock	(8,588)			(8,588)
Repurchase of ICGE common stock, shares				(841,000)
Impact of redeemable noncontrolling interest accretion	(509)				(509)
Impact of subsidiary equity transactions	200				(355)			555
Noncontrolling owners’ share of AOCI of consolidated subsidiary							20	(20)
Net income (loss)	30,022					27,566		2,456
Ending balance at Dec. 31, 2011	253,497		41	(20,619)	3,544,121	(3,277,733)	74	7,613
Ending balance (in shares) at Dec. 31, 2011			40,729,000	(3,281,000)
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options	2,488				2,488
Equity-based compensation related to deferred stock units (DSUs)	419				419
Equity-based compensation related to restricted stock (RS)	3,155				3,155
Issuance of DSUs	107				107
Issuance of DSUs, shares			74,000
Issuance of RS, net of forfeitures and surrenders	(188)				(188)
Issuance of RS, net of forfeitures and surrenders, shares			77,000
Exercise of SARs and stock options, net of surrenders	1,003				1,003
Exercise of SARs and stock options, net of surrenders, shares	(173,208)	[1]	183,000
Repurchase of ICGE common stock	(8,354)			(8,354)
Repurchase of ICGE common stock, shares				(930,000)
Impact of redeemable noncontrolling interest accretion	(839)				(839)
Impact of subsidiary equity transactions	64,014		1		(733)		13	64,733
Noncontrolling owners’ share of AOCI of consolidated subsidiary							(47)	47
Net income (loss)	23,730					22,989		741
Impact of subsidiary equity transactions, shares			1,092,000
Ending balance at Dec. 31, 2012	339,032		42	(28,973)	3,549,533	(3,254,744)	40	73,134
Ending balance (in shares) at Dec. 31, 2012			42,155,000	(4,211,000)
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options	2,377				2,377
Equity-based compensation related to deferred stock units (DSUs)	377				377
Equity-based compensation related to restricted stock (RS)	2,958				2,958
Issuance of DSUs	359				359
Issuance of DSUs, shares			60,000
Issuance of RS, net of forfeitures and surrenders	(609)				(609)
Issuance of RS, net of forfeitures and surrenders, shares			124,000
Exercise of SARs and stock options, net of surrenders	(11,735)		1		(11,736)
Exercise of SARs and stock options, net of surrenders, shares	(1,500)	[1]	994,000
Repurchase of ICGE common stock	(12,025)			(12,025)
Repurchase of ICGE common stock, shares				(907,000)
Impact of redeemable noncontrolling interest accretion	(1,088)				(1,088)
Impact of subsidiary equity transactions	(5,799)				(5,410)			(389)
Net income (loss)	202,146					209,059		(6,913)
Impact of sale of consolidated subsidiaries	(42,315)							(42,315)
Ending balance at Dec. 31, 2013	$ 473,678		$ 43	$ (40,998)	$ 3,536,761	$ (3,045,685)	$ 40	$ 23,517
Ending balance (in shares) at Dec. 31, 2013			43,333,000	(5,118,000)

[1] ICG received cash of less than $0.1 million, $1.0 million and $0.2 million related to stock options exercised during the years ended December 31, 2013, 2012 and 2011.